Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Clinical Evaluation of the iCubate iC-GPC Assay for Detection of Gram-Positive Bacteria and Resistance Markers from Positive Blood Cultures.

Granato PA, Unz MM, Widen RH, Silbert S, Young S, Heflin KL, Conover MS, Buchan BW, Ledeboer NA.

J Clin Microbiol. 2018 Aug 27;56(9). pii: e00485-18. doi: 10.1128/JCM.00485-18. Print 2018 Sep.

2.

The Transcriptional Regulator BpsR Controls the Growth of Bordetella bronchiseptica by Repressing Genes Involved in Nicotinic Acid Degradation.

Guragain M, Jennings-Gee J, Cattelan N, Finger M, Conover MS, Hollis T, Deora R.

J Bacteriol. 2018 May 24;200(12). pii: e00712-17. doi: 10.1128/JB.00712-17. Print 2018 Jun 15.

3.

Structure-based discovery of glycomimetic FmlH ligands as inhibitors of bacterial adhesion during urinary tract infection.

Kalas V, Hibbing ME, Maddirala AR, Chugani R, Pinkner JS, Mydock-McGrane LK, Conover MS, Janetka JW, Hultgren SJ.

Proc Natl Acad Sci U S A. 2018 Mar 20;115(12):E2819-E2828. doi: 10.1073/pnas.1720140115. Epub 2018 Mar 5.

4.

Functional role of the type 1 pilus rod structure in mediating host-pathogen interactions.

Spaulding CN, Schreiber HL 4th, Zheng W, Dodson KW, Hazen JE, Conover MS, Wang F, Svenmarker P, Luna-Rico A, Francetic O, Andersson M, Hultgren S, Egelman EH.

Elife. 2018 Jan 18;7. pii: e31662. doi: 10.7554/eLife.31662.

5.

Bacterial virulence phenotypes of Escherichia coli and host susceptibility determine risk for urinary tract infections.

Schreiber HL 4th, Conover MS, Chou WC, Hibbing ME, Manson AL, Dodson KW, Hannan TJ, Roberts PL, Stapleton AE, Hooton TM, Livny J, Earl AM, Hultgren SJ.

Sci Transl Med. 2017 Mar 22;9(382). pii: eaaf1283. doi: 10.1126/scitranslmed.aaf1283.

6.

Inflammation-Induced Adhesin-Receptor Interaction Provides a Fitness Advantage to Uropathogenic E. coli during Chronic Infection.

Conover MS, Ruer S, Taganna J, Kalas V, De Greve H, Pinkner JS, Dodson KW, Remaut H, Hultgren SJ.

Cell Host Microbe. 2016 Oct 12;20(4):482-492. doi: 10.1016/j.chom.2016.08.013. Epub 2016 Sep 22.

7.

Metabolic Requirements of Escherichia coli in Intracellular Bacterial Communities during Urinary Tract Infection Pathogenesis.

Conover MS, Hadjifrangiskou M, Palermo JJ, Hibbing ME, Dodson KW, Hultgren SJ.

MBio. 2016 Apr 12;7(2):e00104-16. doi: 10.1128/mBio.00104-16.

8.

Establishment and Characterization of UTI and CAUTI in a Mouse Model.

Conover MS, Flores-Mireles AL, Hibbing ME, Dodson K, Hultgren SJ.

J Vis Exp. 2015 Jun 23;(100):e52892. doi: 10.3791/52892.

9.

The unexplored relationship between urinary tract infections and the autonomic nervous system.

Hibbing ME, Conover MS, Hultgren SJ.

Auton Neurosci. 2016 Oct;200:29-34. doi: 10.1016/j.autneu.2015.06.002. Epub 2015 Jun 6. Review.

10.

Uropathogenic Escherichia coli superinfection enhances the severity of mouse bladder infection.

Schwartz DJ, Conover MS, Hannan TJ, Hultgren SJ.

PLoS Pathog. 2015 Jan 8;11(1):e1004599. doi: 10.1371/journal.ppat.1004599. eCollection 2015 Jan.

11.

Pilicide ec240 disrupts virulence circuits in uropathogenic Escherichia coli.

Greene SE, Pinkner JS, Chorell E, Dodson KW, Shaffer CL, Conover MS, Livny J, Hadjifrangiskou M, Almqvist F, Hultgren SJ.

MBio. 2014 Oct 28;5(6):e02038. doi: 10.1128/mBio.02038-14.

12.

Comparative analyses of a cystic fibrosis isolate of Bordetella bronchiseptica reveal differences in important pathogenic phenotypes.

Sukumar N, Nicholson TL, Conover MS, Ganguly T, Deora R.

Infect Immun. 2014 Apr;82(4):1627-37. doi: 10.1128/IAI.01453-13. Epub 2014 Jan 27.

13.

Transcriptome profiling reveals stage-specific production and requirement of flagella during biofilm development in Bordetella bronchiseptica.

Nicholson TL, Conover MS, Deora R.

PLoS One. 2012;7(11):e49166. doi: 10.1371/journal.pone.0049166. Epub 2012 Nov 12.

14.

FHA-mediated cell-substrate and cell-cell adhesions are critical for Bordetella pertussis biofilm formation on abiotic surfaces and in the mouse nose and the trachea.

Serra DO, Conover MS, Arnal L, Sloan GP, Rodriguez ME, Yantorno OM, Deora R.

PLoS One. 2011;6(12):e28811. doi: 10.1371/journal.pone.0028811. Epub 2011 Dec 22.

15.

BpsR modulates Bordetella biofilm formation by negatively regulating the expression of the Bps polysaccharide.

Conover MS, Redfern CJ, Ganguly T, Sukumar N, Sloan G, Mishra M, Deora R.

J Bacteriol. 2012 Jan;194(2):233-42. doi: 10.1128/JB.06020-11. Epub 2011 Nov 4.

16.

Extracellular DNA is essential for maintaining Bordetella biofilm integrity on abiotic surfaces and in the upper respiratory tract of mice.

Conover MS, Mishra M, Deora R.

PLoS One. 2011 Feb 11;6(2):e16861. doi: 10.1371/journal.pone.0016861.

17.

The Bps polysaccharide of Bordetella pertussis promotes colonization and biofilm formation in the nose by functioning as an adhesin.

Conover MS, Sloan GP, Love CF, Sukumar N, Deora R.

Mol Microbiol. 2010 Sep;77(6):1439-55. doi: 10.1111/j.1365-2958.2010.07297.x. Epub 2010 Jul 30.

18.

Cross-species protection mediated by a Bordetella bronchiseptica strain lacking antigenic homologs present in acellular pertussis vaccines.

Sukumar N, Sloan GP, Conover MS, Love CF, Mattoo S, Kock ND, Deora R.

Infect Immun. 2010 May;78(5):2008-16. doi: 10.1128/IAI.01142-09. Epub 2010 Feb 22.

19.

Active and passive immunizations with Bordetella colonization factor A protect mice against respiratory challenge with Bordetella bronchiseptica.

Sukumar N, Love CF, Conover MS, Kock ND, Dubey P, Deora R.

Infect Immun. 2009 Feb;77(2):885-95. doi: 10.1128/IAI.01076-08. Epub 2008 Dec 8.

Supplemental Content

Loading ...
Support Center